arrow
R

Richard G. Bach

University of Missouri System
H指数:48
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy

Mavacamten在非梗阻性肥厚型心肌病中的应用

JACC
IF0
2026-03-250
PRE
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy

Valsartan及早期肥厚型心肌病中的心脏重塑——VANISH随机临床试验的心脏磁共振亚研究

2025-06-010
PRE
Association Between age or Duration of Diagnosis in Obstructive Hypertrophic Cardiomyopathy and Response to Mavacamten Treatment: Exploratory Analysis of the EXPLORER-HCM Trial

梗阻性肥厚型心肌病中年龄或确诊时间与Mavacamten治疗反应关系的关联:EXPLORER-HCM试验的探索性分析

2024-12-070
PRE
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Trial Cardiac Magnetic Resonance Substudy

Valsartan和早期肥厚型心肌病的心脏重塑:VANISH试验心脏磁共振亚研究

2024-11-120
PRE
The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry

Cangrelor在心源性休克中的使用: 来自CAMEO注册表的见解

2024-10-010
PRE
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
2024-08-010
PRE
Quality of Life in EarlyStage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
2023-11-070
PRE
Cardiac Remodeling in Subclinical Hypertrophic CardiomyopathyThe VANISH Randomized Clinical Trial
2023-11-019
OA
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

缬沙坦治疗早期肥厚型心肌病: 一项2期随机试验

2021-09-2379
OA